ADA Member Exclusive Webinar—Join fellow American Diabetes Association® (ADA) professional members for an exclusive, live one-hour webinar featuring an expert panel discussion on the use of GLP‑1 receptor agonists in older adults with type 2 diabetes. This session will examine the clinical benefits and risks of GLP‑1 therapies for individuals with type 2 diabetes and obesity, with a focused look at considerations unique to aging populations—including frailty, polypharmacy, renal function, and other factors that influence therapeutic decision-making.
Participants will gain practical guidance on applying current evidence and guidelines to support personalized treatment approaches for older adults. The discussion will also address gaps in existing data and outline strategies to optimize safety, tolerability, and adherence when prescribing GLP‑1 medicines in this population.
Note: This webinar will be live-only – no recording will be available.